Overview

Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects

Status:
Not yet recruiting
Trial end date:
2023-03-15
Target enrollment:
Participant gender:
Summary
A Randomized, Double-Blind, Placebo-controlled, Parallel Design Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects
Phase:
N/A
Details
Lead Sponsor:
Vedic Lifesciences Pvt. Ltd.